Mostrar el registro sencillo del ítem

Niveles de autoanticuerpos anti-peptidos carbamilados y citrulinados y su relación con índices de actividad clínica reumática en pacientes con artritis reumatoide temprana y familiares en primer grado de consanguinidad de pacientes con artritis reumatoide, oriundos de Colombia

dc.contributor.advisorRomero Sánchez, María Consuelo
dc.contributor.advisorChila Moreno, Leidy Lorena
dc.contributor.advisorMuñoz Henao, Julián Esteban
dc.contributor.authorRamos Casallas, Manuel Alejandro
dc.date.accessioned2022-03-09T16:33:00Z
dc.date.available2022-03-09T16:33:00Z
dc.date.issued2018-05
dc.identifier.urihttps://repositorio.unicolmayor.edu.co/handle/unicolmayor/4792
dc.description.abstractLa Artritis Reumatoide (AR) es una enfermedad autoinmune sistémica caracterizada por un estado de inflamación crónica y deterioro progresivo de las articulaciones. Su diagnóstico se basa en una serie de criterios clínicos y pruebas de laboratorio. Este último ítem abarca la detección del Factor Reumatoide (FR) y/o los autoanticuerpos anti-proteínas citrulinadas (anti-CCP), asociados a la actividad de la enfermedad y al pronóstico de la misma. Sin embargo, existen grupos de pacientes con elevado daño articular y niveles indetectables de FR y/o autoautoanticuerpos anti-CCP, dificultando el diagnóstico y las opciones terapéuticas. De forma reciente se descubrieron los autoanticuerpos anti-proteínas carbamiladas (anti-CarP) asociados a esta enfermedad, los cuales permitirían tipificar la AR en estos grupos de pacientes e individuos con condiciones de riesgo, además de poder predecir el desenlace articular. De esta manera se facilitaría el diagnóstico, así como en el tratamiento y el pronóstico. En este estudio se midieron los niveles de autoautoanticuerpos anti-CCP. Así mismo, se midieron los niveles de autoanticuerpos frente al péptido carbamilado de fibrinógeno (empleando el péptido nativo como control), en pacientes con artritis reumatoide temprana y familiares en primer grado de consanguinidad, para establecer su asociación frente al daño reumatológico y periodontal. Los resultados resaltan la asociación entre el número de articulaciones dolorosas e inflamadas y el daño periodontal con la presencia de los anticuerpos anti-péptido de fibrinógeno carbamilado en el grupo de familiares en primer grado de consanguinidad. No hubo asociación entre estos autoanticuerpos y los autoautoanticuerpos anti-CCP en los pacientes con artritis reumatoide temprana. Como hallazgo adicional, se observó que los dos grupos de estudio presentan autoanticuerpos contra el péptido nativo de fibrinógeno. En conclusión, la presencia de autoanticuerpos contra péptidos/proteínas carbamiladas están presentes en la población colombiana con artritis reumatoide temprana y familiares en primer grado de consanguinidad; asociados a manifestaciones de daño articular y periodontal. Además, la presencia de autoanticuerpos frente al péptido de fibrinógeno nativo puede ser un indicio de desarrollo de la enfermedad.spa
dc.description.tableofcontentsTABLA DE CONTENIDO RESUMEN EJECUTIVO 11 INTRODUCCIÓN 13 1. OBJETIVOS 15 1.1. OBJETIVO PRINCIPAL (GENERAL )15 1.2. OBJETIVOS SECUNDARIOS (ESPECÍFICOS)15 2. ANTECEDENTES 17 3. MARCO TEÓRICO 24 3.1. DEFINICIÓN DE ARTRITIS REUMATOIDE 24 3.2. MANIFESTACIONES CLÍNICAS 27 3.3. FACTORES DE RIESGO 28 3.4. EPIDEMIOLOGÍA DE LA ENFERMEDAD EN COLOMBIA. 34 3.5. DIAGNÓSTICO 35 4. METODOLOGÍA 44 4.1. TIPO DE INVESTIGACIÓN 44 4.2. POBLACIÓN 44 4.3. MUESTRA 44 4.4. SELECCIÓN DE LA MUESTRA 44 4.5. CRITERIOS DE INCLUSIÓN 45 4.6. CRITERIOS DE EXCLUSIÓN 45 4.7. HIPÓTESIS 47 4.8. TÉCNICAS Y PROCEDIMIENTOS 48 4.9. ANÁLISIS ESTADÍSTICO 51 5. RESULTADOS 52 6. DISCUSIÓN 86 7. CONCLUSIONES 91 8. REFERENCIAS 92 9. ANEXOS 116 9.1. FORMATO DE CRITERIOS DE EXCLUSION 116 9.2. FORMATO DE RECOLECCION DE DATOS PACIENTES CON AR Y FAMILIARES: 117spa
dc.format.extent117p.spa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherUniversidad Colegio Mayor de Cundinamarcaspa
dc.rightsDerechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2018spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.titleNiveles de autoanticuerpos anti-peptidos carbamilados y citrulinados y su relación con índices de actividad clínica reumática en pacientes con artritis reumatoide temprana y familiares en primer grado de consanguinidad de pacientes con artritis reumatoide, oriundos de Colombiaspa
dc.typeTrabajo de grado - Pregradospa
dc.description.degreelevelPregradospa
dc.description.degreenameBacteriólogo(a) y Laboratorista Clínicospa
dc.identifier.barcode58418
dc.publisher.facultyFacultad de Ciencias de la Saludspa
dc.publisher.placeBogotá D.Cspa
dc.publisher.programBacteriología y Laboratorio Clínicospa
dc.relation.referencesFirestein GS. Evolving concepts of rheumatoid arthritis. Nature [Internet]. 2003 May 15;423(6937):356–61. Available from: http://www.nature.com/doifinder/10.1038/nature01661spa
dc.relation.referencesKlareskog L, Rönnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol [Internet]. 2008;26:651–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18173373spa
dc.relation.referencesWegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, Feldmann M, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev. 2010;233(1):34–54.spa
dc.relation.referencesRosales-borjas DM, Arévalo MA, Ortiz-ortiz L. Artritis reumatoide: importancia de los antigenos citrulinados en el diagnostico del padecimiento. Rev Médica la Extensión Port. 2009;4(3):125–30.spa
dc.relation.referencesNishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med [Internet]. 2007 Jun 5;146(11):797–808. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17548411spa
dc.relation.referencesvan Venrooij WJ, Hazes JM, Visser H. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med. 2002;60(10):383–8.spa
dc.relation.referencesRantapää-Dahlqvist S, de Jong BAW, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum [Internet]. 2003 Oct;48(10):2741–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14558078spa
dc.relation.referencesvan der Helm-van Mil AHM, Verpoort KN, Breedveld FC, Toes REM, Huizinga TWJ. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther [Internet]. 2005;7(5):R949-58. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1257421&tool=pm centrez&rendertype=abstractspa
dc.relation.referencesVan Der Woude D, Young A, Jayakumar K, Mertens BJ, Toes REM, Van Der Heijde D, et al. Prevalence of and predictive factors for sustained diseasemodifying antirheumatic drug-free remission in rheumatoid arthritis: Results from two large early arthritis cohorts. Arthritis Rheum [Internet]. 2009 Aug;60(8):2262–71. Available from: http://doi.wiley.com/10.1002/art.24661spa
dc.relation.referencesVan Der Woude D, Young A, Jayakumar K, Mertens BJ, Toes REM, Van Der Heijde D, et al. Prevalence of and predictive factors for sustained diseasemodifying antirheumatic drug-free remission in rheumatoid arthritis: Results from two large early arthritis cohorts. Arthritis Rheum [Internet]. 2009 Aug;60(8):2262–71. Available from: http://doi.wiley.com/10.1002/art.24661spa
dc.relation.referencesNielen MMJ, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MHMT, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum [Internet]. 2004 Feb;50(2):380–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14872479spa
dc.relation.referencesWillemze A, Trouw L a, Toes REM, Huizinga TWJ. The influence of ACPA status and characteristics on the course of RA. Nat Rev Rheumatol [Internet]. 2012;8(3):144–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22293763spa
dc.relation.referencesBerglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, et al. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis [Internet]. 2006 Apr;65(4):453–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16176994spa
dc.relation.referencesShi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GMC, van Veelen P a., et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci. 2011;108(42):17372–7.spa
dc.relation.referencesSteinbrecher UP, Fisher M, Witztum JL, Curtiss LK. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. J Lipid Res [Internet]. 1984 Oct;25(10):1109–16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6439810spa
dc.relation.referencesMydel P, Wang Z, Brisslert M, Hellvard A, Dahlberg LE, Hazen SL, et al. Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J Immunol [Internet]. 2010 Jun 15;184(12):6882–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20488785spa
dc.relation.referencesShi J, Van De Stadt LA, Levarht EWN, Huizinga TWJ, Toes REM, Trouw LA, et al. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum. 2013;65(4):911–5.spa
dc.relation.referencesYee A, Webb T, Seaman A, Infantino M, Meacci F, Manfredi M, et al. AntiCarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. Immunol Res. 2014;61(1–2):24– 30.spa
dc.relation.referencesShi J, van de Stadt L a, Levarht EWN, Huizinga TWJ, Hamann D, van Schaardenburg D, et al. Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis [Internet]. 2014;73(4):780–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24336334spa
dc.relation.referencesBrink M, Verheul MK, Rönnelid J, Berglin E, Holmdahl R, Toes REM, et al. Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage. Arthritis Res Ther [Internet]. 2015;17:25. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4350267&tool=pm centrez&rendertype=abstractspa
dc.relation.referencesJiang X, Trouw L a, van Wesemael TJ, Shi J, Bengtsson C, Källberg H, et al. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Ann Rheum Dis [Internet]. 2014;1761–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24812286spa
dc.relation.referencesGan RW, Trouw LA, Shi J, Toes REM, Huizinga TWJ, Demoruelle MK, et al. Anti-carbamylated Protein Antibodies Are Present Prior to Rheumatoid Arthritis and Are Associated with Its Future Diagnosis. J Rheumatol [Internet]. 2015 Apr 1;42(4):572–9. Available from: http://www.jrheum.org/cgi/doi/10.3899/jrheum.140767spa
dc.relation.referencesShi J, van Steenbergen HW, van Nies JAB, Levarht EWN, Huizinga TWJ, van der Helm-van Mil AHM, et al. The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis. Arthritis Res Ther [Internet]. 2015;17(1):339. Available from: http://arthritisresearch.com/content/17/1/339spa
dc.relation.referencesAlessandri C, Bartosiewicz I, Pendolino M, Mancini R, Colasanti T, Pecani A, et al. Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: Lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor. Clin Exp Rheumatol. 2015;33(6):824–30.spa
dc.relation.referencesKoppejan H, Trouw LA, Sokolove J, Lahey LJ, Huizinga TJW, Smolik IA, et al. Role of Anti-Carbamylated Protein Antibodies Compared to Anti- Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls. Arthritis Rheumatol [Internet]. 2016 Sep;68(9):2090–8. Available from: http://doi.wiley.com/10.1002/art.39664spa
dc.relation.referencesReed E, Jiang X, Kharlamova N, Ytterberg AJ, Catrina AI, Israelsson L, et al. Antibodies to carbamylated α -enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies. Arthritis Res Ther [Internet]. 2016;1–9. Available from: http://dx.doi.org/10.1186/s13075-016-1001-6spa
dc.relation.referencesMontes A, Regueiro C, Perez-Pampin E, Boveda MD, Gomez-Reino JJ, Gonzalez A. Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies. Kuwana M, editor. PLoS One [Internet]. 2016 Aug 18;11(8):e0161141. Available from: http://dx.plos.org/10.1371/journal.pone.0161141spa
dc.relation.referencesGibofsky A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care [Internet]. 2012 Dec;18(13 Suppl):S295-302. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23327517spa
dc.relation.referencesMcInnes IB, Schett G. The Pathogenesis of Rheumatoid Arthritis. N Engl J Med [Internet]. 2011 Dec 8;365(23):2205–19. Available from: http://rcnpublishing.com/doi/abs/10.7748/phc2011.11.21.9.29.c8797spa
dc.relation.referencesBurska AN, Hunt L, Boissinot M, Strollo R, Ryan BJ, Vital E, et al. Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis. Mediators Inflamm [Internet]. 2014;2014:1–19. Available from: http://www.hindawi.com/journals/mi/2014/492873/spa
dc.relation.referencesNissim A, Winyard PG, Corrigall V, Fatah R, Perrett D, Panayi G, et al. Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint. Arthritis Rheum [Internet]. 2005 Dec;52(12):3829–38. Available from: http://doi.wiley.com/10.1002/art.21479spa
dc.relation.referencesMarcinkiewicz J, Biedroń R, Maresz K, Kwaśny-Krochin B, Bobek M, Kontny E, et al. Oxidative modification of type II collagen differentially affects its arthritogenic and tolerogenic capacity in experimental arthritis. Arch Immunol Ther Exp (Warsz) [Internet]. 52(4):284–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15467493spa
dc.relation.referencesAnderton SM. Post-translational modifications of self antigens: implications for autoimmunity. Curr Opin Immunol [Internet]. 2004 Dec;16(6):753–8. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0952791504001451spa
dc.relation.referencesEggleton P, Nissim A, Ryan BJ, Whiteman M, Winyard PG. Detection and isolation of human serum autoantibodies that recognize oxidatively modified autoantigens. Free Radic Biol Med [Internet]. 2013 Apr;57:79–91. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0891584912018060spa
dc.relation.referencesValesini G, Gerardi MC, Iannuccelli C, Pacucci VA, Pendolino M, Shoenfeld Y. Citrullination and autoimmunity. Autoimmun Rev [Internet]. 2015 Jun;14(6):490–7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1568997215000282spa
dc.relation.referencesBaka Z, György B, Géher P, Buzás EI, Falus A, Nagy G. Citrullination under physiological and pathological conditions. Jt Bone Spine [Internet]. 2012 Oct;79(5):431–6. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1297319X12000127spa
dc.relation.referencesCantagrel A, Degboé Y. New autoantibodies associated with rheumatoid arthritis recognize posttranslationally modified self-proteins. Joint Bone Spine [Internet]. 2015;83(1):11–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26639222spa
dc.relation.referencesGerlag DM, Raza K, van Baarsen LGM, Brouwer E, Buckley CD, Burmester GR, et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis. 2012;71(5):638–41.spa
dc.relation.referencesAletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.spa
dc.relation.referencesO’Dell J. Rheumatoid arthritis. In: Goldman L, Schafer AI E, editor. Goldman’s Cecil Medicine. 25th ed. Philadelphia: Elsevier Saunders; 2016.spa
dc.relation.referencesGregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum [Internet]. 1987 Nov;30(11):1205–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2446635spa
dc.relation.referencesBax M, van Heemst J, Huizinga TWJ, Toes REM. Genetics of rheumatoid arthritis: what have we learned? Immunogenetics [Internet]. 2011 Aug 10;63(8):459–66. Available from: http://link.springer.com/10.1007/s00251- 011-0528-6spa
dc.relation.referencesHutchinson D, Shepstone L, Moots R, Lear JT, Lynch MP. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis [Internet]. 2001 Mar;60(3):223–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11171682spa
dc.relation.referencesKällberg H, Ding B, Padyukov L, Bengtsson C, Rönnelid J, Klareskog L, et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis [Internet]. 2011 Mar;70(3):508–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21149499spa
dc.relation.referencesKarlson EW, Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum [Internet]. 1999 May;42(5):910–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10323446spa
dc.relation.referencesKochi Y, Suzuki A, Yamamoto K. Genetic basis of rheumatoid arthritis: A current review. Biochem Biophys Res Commun [Internet]. 2014;452(2):254– 62. Available from: http://dx.doi.org/10.1016/j.bbrc.2014.07.085spa
dc.relation.referencesSuzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet [Internet]. 2003 Aug 29;34(4):395–402. Available from: http://www.nature.com/doifinder/10.1038/ng1206spa
dc.relation.referencesKochi Y, Suzuki A, Yamada R, Yamamoto K. Ethnogenetic heterogeneity of rheumatoid arthritis—implications for pathogenesis. Nat Rev Rheumatol [Internet]. 2010 May 16;6(5):290–5. Available from: http://www.nature.com/doifinder/10.1038/nrrheum.2010.23spa
dc.relation.referencesNakashima K, Hagiwara T, Ishigami A, Nagata S, Asaga H, Kuramoto M, et al. Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3). J Biol Chem [Internet]. 1999 Sep 24;274(39):27786–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10488123spa
dc.relation.referencesIrigoyen P, Lee AT, Wener MH, Li W, Kern M, Batliwalla F, et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: Contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum [Internet]. 2005 Dec;52(12):3813–8. Available from: http://doi.wiley.com/10.1002/art.21419spa
dc.relation.referencesCha S, Choi C-B, Han T-U, Kang CP, Kang C, Bae S-C. Association of Anti– Cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis. Arthritis Rheum [Internet]. 2007 May;56(5):1454–63. Available from: http://doi.wiley.com/10.1002/art.22570spa
dc.relation.referencesGregersen PK, Lee H-S, Batliwalla F, Begovich AB. PTPN22: Setting thresholds for autoimmunity. Semin Immunol [Internet]. 2006 Aug;18(4):214– 23. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1044532306000467spa
dc.relation.referencesCohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood [Internet]. 1999 Mar 15;93(6):2013–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10068674spa
dc.relation.referencesVang T, Miletic A V, Arimura Y, Tautz L, Rickert RC, Mustelin T. Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol [Internet]. 2008;26:29–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18303998spa
dc.relation.referencesThomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J, et al. Rheumatoid arthritis association at 6q23. Nat Genet [Internet]. 2007 Dec 4;39(12):1431– 3. Available from: http://www.nature.com/doifinder/10.1038/ng.2007.32spa
dc.relation.referencesThomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J, et al. Rheumatoid arthritis association at 6q23. Nat Genet [Internet]. 2007 Dec 4;39(12):1431– 3. Available from: http://www.nature.com/doifinder/10.1038/ng.2007.32spa
dc.relation.referencesMusone SL, Taylor KE, Lu TT, Nititham J, Ferreira RC, Ortmann W, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet [Internet]. 2008 Sep 1;40(9):1062–4. Available from: http://www.nature.com/doifinder/10.1038/ng.202spa
dc.relation.referencesMatmati M, Jacques P, Maelfait J, Verheugen E, Kool M, Sze M, et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet [Internet]. 2011 Aug 14;43(9):908–12. Available from: http://www.nature.com/doifinder/10.1038/ng.874spa
dc.relation.referencesAdrianto I, Wen F, Templeton A, Wiley G, King JB, Lessard CJ, et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet [Internet]. 2011 Mar 20;43(3):253–8. Available from: http://www.nature.com/doifinder/10.1038/ng.766spa
dc.relation.referencesZheng J, Yin J, Huang R, Petersen F, Yu X. Meta-analysis reveals an association of STAT4 polymorphisms with systemic autoimmune disorders and anti-dsDNA antibody. Hum Immunol [Internet]. 2013 Aug;74(8):986–92. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0198885913001201spa
dc.relation.referencesKariuki SN, Kirou KA, MacDermott EJ, Barillas-Arias L, Crow MK, Niewold TB. Cutting Edge: Autoimmune Disease Risk Variant of STAT4 Confers Increased Sensitivity to IFN- in Lupus Patients In Vivo. J Immunol [Internet]. 2009 Jan 1;182(1):34–8. Available from: http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.182.1.34spa
dc.relation.referencesHirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med [Internet]. 2007 Nov 26;204(12):2803–12. Available from: http://www.jem.org/lookup/doi/10.1084/jem.20071397spa
dc.relation.referencesNagpal R, Yamashiro Y, Izumi Y. The Two-Way Association of Periodontal Infection with Systemic Disorders: An Overview. Mediators Inflamm [Internet]. 2015;2015:1–9. Available from: http://www.hindawi.com/journals/mi/2015/793898/spa
dc.relation.referencesLiubomorova I. State of periodontium in patients affected with rheumatism. Stomatologiia (Mosk). 1964;33 – 37.spa
dc.relation.referencesMikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, et al. Periodontitis and Porphyromonas gingivalis in Patients With Rheumatoid Arthritis. Arthritis Rheumatol [Internet]. 2014 May;66(5):1090–100. Available from: http://doi.wiley.com/10.1002/art.38348spa
dc.relation.referencesMercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol [Internet]. 2000 Apr;27(4):267–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10783841spa
dc.relation.referencesMercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol [Internet]. 2000 Apr;27(4):267–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10783841spa
dc.relation.referencesArkema E V., Karlson EW, Costenbader KH. A Prospective Study of Periodontal Disease and Risk of Rheumatoid Arthritis. J Rheumatol [Internet]. 2010 Sep 1;37(9):1800–4. Available from: http://www.jrheum.org/cgi/doi/10.3899/jrheum.091398spa
dc.relation.referencesAbdelsalam SK, Hashim NT, Elsalamabi EM, Gismalla BG. Periodontal status of rheumatoid arthritis patients in khartoum state. BMC Res Notes [Internet]. 2011;4(1):460. Available from: http://bmcresnotes.biomedcentral.com/articles/10.1186/1756-0500-4-460spa
dc.relation.referencesGleissner C, Willershausen B, Kaesser U, Bolten WW. The role of risk factors for periodontal disease in patients with rheumatoid arthritis. Eur J Med Res [Internet]. 1998 Aug 18;3(8):387–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9707521spa
dc.relation.referencesKässer UR, Gleissner C, Dehne F, Michel A, Willershausen-Zönnchen B, Bolten WW. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum [Internet]. 1997 Dec;40(12):2248–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9416864spa
dc.relation.referencesCooles FAH, Isaacs JD. Pathophysiology of rheumatoid arthritis. Curr Opin Rheumatol [Internet]. 2011 May;23(3):233–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21427580spa
dc.relation.referencesSocransky SS, Haffajee AD. Effect of Therapy on Periodontal Infections. J Periodontol [Internet]. 1993 Aug;64(8s):754–9. Available from: http://www.joponline.org/doi/10.1902/jop.1993.64.8s.754spa
dc.relation.referencesHolt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000 [Internet]. 1999 Jun;20:168– 238. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10522227spa
dc.relation.referencesKesavalu L, Holt SC, Ebersole JL. Trypsin-like protease activity of Porphyromonas gingivalis as a potential virulence factor in a murine lesion model. Microb Pathog [Internet]. 1996 Jan;20(1):1–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8692006spa
dc.relation.referencesBirkedal-Hansen H, Taylor RE, Zambon JJ, Barwa PK, Neiders ME. Characterization of collagenolytic activity from strains of Bacteroides gingivalis. J Periodontal Res [Internet]. 1988 Jul;23(4):258–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2846816spa
dc.relation.referencesLamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev [Internet]. 1998 Dec;62(4):1244–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9841671spa
dc.relation.referencesMcGraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun [Internet]. 1999 Jul;67(7):3248–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10377098spa
dc.relation.referencesWegner N, Wait R, Sroka A, Eick S, Nguyen K-A, Lundberg K, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum [Internet]. 2010 Sep;62(9):2662–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20506214spa
dc.relation.referencesBatool H, Afzal N, Shahzad F, Kashif M. Relationship between rheumatoid arthritis and chronic periodontitis. J Med Radiol Pathol Surg [Internet]. 2016;2(6):11–4. Available from: http://www.joponline.org/doi/abs/10.1902/jop.2001.72.6.779%5Cnhttp://www. ncbi.nlm.nih.gov/pubmed/11453241spa
dc.relation.referencesKoziel J, Mydel P, Potempa J. The link between periodontal disease and rheumatoid arthritis: an updated review. Curr Rheumatol Rep [Internet]. 2014 Mar;16(3):408. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24458478spa
dc.relation.referencesMangat P, Wegner N, Venables PJ, Potempa J. Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis? Arthritis Res Ther [Internet]. 2010;12(3):209. Available from: http://arthritisresearch.biomedcentral.com/articles/10.1186/ar3000spa
dc.relation.referencesRodríguez SB, Stitt BL, Ash DE. Cysteine 351 is an essential nucleophile in catalysis by Porphyromonas gingivalis peptidylarginine deiminase. Arch Biochem Biophys [Internet]. 2010 Dec;504(2):190–6. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0003986110003838spa
dc.relation.referencesFarquharson D, Butcher JP, Culshaw S. Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis. Mucosal Immunol [Internet]. 2012;5(2):112–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22274780spa
dc.relation.referencesBrinkmann V. Neutrophil Extracellular Traps Kill Bacteria. Science (80- ) [Internet]. 2004 Mar 5;303(5663):1532–5. Available from: http://www.sciencemag.org/cgi/doi/10.1126/science.1092385spa
dc.relation.referencesBrinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol [Internet]. 2007 Aug;5(8):577–82. Available from: http://www.nature.com/doifinder/10.1038/nrmicro1710spa
dc.relation.referencesNeeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol [Internet]. 2008 Feb 1;180(3):1895–902. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18209087spa
dc.relation.referencesKlareskog L, Malmström V, Lundberg K, Padyukov L, Alfredsson L. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol [Internet]. 2011 Apr;23(2):92–8. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1044532311000157spa
dc.relation.referencesKlareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum [Internet]. 2006 Jan;54(1):38–46. Available from: http://doi.wiley.com/10.1002/art.21575spa
dc.relation.referencesMakrygiannakis D, Hermansson M, Ulfgren A-K, Nicholas AP, Zendman AJW, Eklund A, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis [Internet]. 2008 Oct 1;67(10):1488–92. Available from: http://ard.bmj.com/cgi/doi/10.1136/ard.2007.075192spa
dc.relation.referencesPadyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum [Internet]. 2004 Oct;50(10):3085–92. Available from: http://doi.wiley.com/10.1002/art.20553spa
dc.relation.referencesLinn-Rasker SP. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis [Internet]. 2006 Mar 1;65(3):366–71. Available from: http://ard.bmj.com/cgi/doi/10.1136/ard.2005.041079spa
dc.relation.referencesPedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, et al. Strong combined gene–environment effects in anti–cyclic citrullinated peptide–positive rheumatoid arthritis: A nationwide case–control study in Denmark. Arthritis Rheum [Internet]. 2007 May;56(5):1446–53. Available from: http://doi.wiley.com/10.1002/art.22597spa
dc.relation.referencesLundström E, Källberg H, Alfredsson L, Klareskog L, Padyukov L. Geneenvironment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: All alleles are important. Arthritis Rheum [Internet]. 2009 Jun;60(6):1597–603. Available from: http://doi.wiley.com/10.1002/art.24572spa
dc.relation.referencesAnaya JM, Correa PA, Mantilla R, Jiménez F, Kuffner T MJ. Rheumatoid arthritis in African Colombians from Quibdó. Semin Arthritis Rheum [Internet]. 2001;31:191–8. Available from: http://www.semarthritisrheumatism.com/article/S0049-0172(01)33477- 7/abstractspa
dc.relation.referencesDiaz JA, Dávila-Ramírez FA, Quintana-López G, Aristizábal-Gutiérrez F, Brown P. Prevalencia de artritis reumatoide en Colombia: Una aproximación basada en la carga de la enfermedad año 2005. Rheumatoid Arthritis prevalence in Colombia: An approach based on burden of disease study 2005. 2015;3(1):11–6.spa
dc.relation.referencesMachado-Alba JE, Ruiz AF, Medina Morales DA. The epidemiology of rheumatoid arthritis in a cohort of Colombian patients. Rev Colomb Reumatol [Internet]. 2015;22(3):148–52. Available from: http://www.sciencedirect.com/science/article/pii/S012181231500047Xspa
dc.relation.referencesMuñetón, G. A.; Quintana G. La epidemiología de la artritis reumatoide. Rev Colomb Reumatol [Internet]. 2016;2(3):145–7. Available from: http://www.scielo.org.co/pdf/rcre/v22n3/v22n3a01.pdfspa
dc.relation.referencesBright R, Proudman SM, Rosenstein ED, Bartold PM. Is there a link between carbamylation and citrullination in periodontal disease and rheumatoid arthritis? Med Hypotheses [Internet]. 2015 Jun;84(6):570–6. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0306987715001115spa
dc.relation.referencesKroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van’t Hof M, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum [Internet]. 2000 Aug;43(8):1831–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10943873spa
dc.relation.referencesKroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van’t Hof M, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum [Internet]. 2000 Aug;43(8):1831–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10943873spa
dc.relation.referencesAggarwal R, Liao K, Nair R, Ringold S, Costenbander KH. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Care Res (Hoboken) [Internet]. 2009 Nov 15;61(11):1472– 83. Available from: http://doi.wiley.com/10.1002/art.24827spa
dc.relation.referencesLiao F, Li Z, Wang Y, Shi B, Gong Z, Cheng X. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis. Med Hypotheses [Internet]. 2009 Jun;72(6):732–5. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0306987709000504spa
dc.relation.referencesOrgován G, Noszál B. The complete microspeciation of arginine and citrulline. J Pharm Biomed Anal [Internet]. 2011 Apr;54(5):965–71. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0731708510006667spa
dc.relation.referencesCarrasco-Marín E, Paz-Miguel JE, López-Mato P, Alvarez-Domínguez C, Leyva-Cobián F. Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells. Immunology [Internet]. 1998 Nov;95(3):314–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9824492spa
dc.relation.referencesSzodoray P, Szabó Z, Kapitány A, Gyetvai Á, Lakos G, Szántó S, et al. Anticitrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev [Internet]. 2010 Jan;9(3):140–3. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1568997209001116spa
dc.relation.referencesNagata S, Yamagiwa M, Inoue K, Senshu T. Estrogen regulates peptidylarginine deiminase levels in a rat pituitary cell line in culture. J Cell Physiol [Internet]. 1990 Nov;145(2):333–9. Available from: http://doi.wiley.com/10.1002/jcp.1041450219spa
dc.relation.referencesSebbag M, Chapuy-Regaud S, Auger I, Petit-Texeira E, Clavel C, Nogueira L, et al. Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis. Jt Bone Spine [Internet]. 2004 Nov;71(6):493–502. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1297319X04001460spa
dc.relation.referencesMasson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, et al. The Major Synovial Targets of the Rheumatoid ArthritisSpecific Antifilaggrin Autoantibodies Are Deiminated Forms of the - and - Chains of Fibrin. J Immunol [Internet]. 2001 Mar 15;166(6):4177–84. Available from: http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.166.6.4177spa
dc.relation.referencesSebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, et al. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol [Internet]. 2006 Aug;36(8):2250–63. Available from: http://doi.wiley.com/10.1002/eji.200535790spa
dc.relation.referencesBang H, Egerer K, Gauliard A, Lüthke K, Rudolph PE, Fredenhagen G, et al. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum [Internet]. 2007 Aug;56(8):2503–11. Available from: http://doi.wiley.com/10.1002/art.22817spa
dc.relation.referencesKinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther [Internet]. 2005;7(6):R1421-9. Available from: http://arthritisresearch.biomedcentral.com/articles/10.1186/ar1845spa
dc.relation.referencesFoulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Méchin M-C, et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum [Internet]. 2007 Nov;56(11):3541–53. Available from: http://doi.wiley.com/10.1002/art.22983spa
dc.relation.referencesQuirke A-M, Fisher BAC, Kinloch AJ, Venables PJ. Citrullination of autoantigens: Upstream of TNFα in the pathogenesis of rheumatoid arthritis. FEBS Lett [Internet]. 2011 Dec 1;585(23):3681–8. Available from: http://doi.wiley.com/10.1016/j.febslet.2011.06.006spa
dc.relation.referencesVander Cruyssen B, Cantaert T, Nogueira L, Clavel C, De Rycke L, Dendoven A, et al. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res Ther [Internet]. 2006;8(4):R122. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16859515spa
dc.relation.referencesChapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol [Internet]. 2005 Mar;139(3):542–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15730401spa
dc.relation.referencesBerlyne GM. Carbamylated proteins and peptides in health and in uremia. Nephron [Internet]. 1998;79(2):125–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9647489spa
dc.relation.referencesNolte W. Microbiología Odontológica. México: Editorial Interamericana; 1985.spa
dc.relation.referencesShi J, van Veelen PA, Mahler M, Janssen GMC, Drijfhout JW, Huizinga TWJ, et al. Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmun Rev [Internet]. 2014;13(3):225–30. Available from: http://dx.doi.org/10.1016/j.autrev.2013.10.008spa
dc.relation.referencesTrepanier DJ, Thibert RJ. Carbamylation of erythrocyte membrane aminophospholipids: an in vitro and in vivo study. Clin Biochem [Internet]. 1996 Aug;29(4):333–45. Available from: http://linkinghub.elsevier.com/retrieve/pii/0009912096000185spa
dc.relation.referencesLapko VN, Smith DL, Smith JB. Methylation and carbamylation of human γcrystallins. Protein Sci [Internet]. 2003 Aug;12(8):1762–74. Available from: http://doi.wiley.com/10.1110/ps.0305403spa
dc.relation.referencesWang Z, Nicholls SJ, Rodriguez ER, Kummu O, Hörkkö S, Barnard J, et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med [Internet]. 2007;13(10):1176–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17828273spa
dc.relation.referencesHolzer M, Zangger K, El-Gamal D, Binder V, Curcic S, Konya V, et al. Myeloperoxidase-Derived Chlorinating Species Induce Protein Carbamylation Through Decomposition of Thiocyanate and Urea: Novel Pathways Generating Dysfunctional High-Density Lipoprotein. Antioxid Redox Signal [Internet]. 2012 Oct 15;17(8):1043–52. Available from: http://online.liebertpub.com/doi/abs/10.1089/ars.2011.4403spa
dc.relation.referencesKalmár J, Woldegiorgis KL, Biri B, Ashby MT. Mechanism of Decomposition of the Human Defense Factor Hypothiocyanite Near Physiological pH. J Am Chem Soc [Internet]. 2011 Dec 14;133(49):19911–21. Available from: http://pubs.acs.org/doi/abs/10.1021/ja2083152spa
dc.relation.referencesKlebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol [Internet]. 2005 Jan 26;77(5):598–625. Available from: http://www.jleukbio.org/cgi/doi/10.1189/jlb.1204697spa
dc.relation.referencesJaisson S, Pietrement C, Gillery P. Carbamylation-Derived Products: Bioactive Compounds and Potential Biomarkers in Chronic Renal Failure and Atherosclerosis. Clin Chem [Internet]. 2011 Nov 1;57(11):1499–505. Available from: http://www.clinchem.org/cgi/doi/10.1373/clinchem.2011.163188spa
dc.relation.referencesJaisson S, Gillery P. Evaluation of Nonenzymatic Posttranslational Modification-Derived Products as Biomarkers of Molecular Aging of Proteins. Clin Chem [Internet]. 2010 Sep 1;56(9):1401–12. Available from: http://www.clinchem.org/cgi/doi/10.1373/clinchem.2010.145201spa
dc.relation.referencesSong YW, Kang EH. Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. QJM [Internet]. 2010 Mar 1;103(3):139–46. Available from: https://academic.oup.com/qjmed/articlelookup/doi/10.1093/qjmed/hcp165spa
dc.relation.referencesWernick RM, Lipsky PE, Marban-Arcos E, Maliakkal JJ, Edelbaum D, Ziff M. IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum [Internet]. 1985 Jul;28(7):742–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4015721spa
dc.relation.referencesJones V, Taylor PC, Jacoby RK, Wallington TB. Synovial synthesis of rheumatoid factors and immune complex constituents in early arthritis. Ann Rheum Dis [Internet]. 1984 Apr;43(2):235–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6712294spa
dc.relation.referencesNell VPK. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis [Internet]. 2005 Dec 1;64(12):1731–6. Available from: http://ard.bmj.com/cgi/doi/10.1136/ard.2005.035691spa
dc.relation.referencesArnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum [Internet]. 1988 Mar;31(3):315–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3358796spa
dc.relation.referencesArend WP, Firestein GS. Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat Rev Rheumatol [Internet]. 2012;8(10):573– 86. Available from: http://dx.doi.org/10.1038/nrrheum.2012.134spa
dc.relation.referencesOtterness IG. The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum [Internet]. 1994 Oct;24(2):91–104. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7839158spa
dc.relation.referencesBrigden M. The erythrocyte sedimentation rate. Postgrad Med [Internet]. 1998 May 30;103(5):257–74. Available from: http://www.sciencedirect.com/science/article/pii/S0736467997001972%5Cnh ttp://www.ncbi.nlm.nih.gov/pubmed/9404806spa
dc.relation.referencesKushner I. C-reactive protein in rheumatology. Arthritis Rheum [Internet]. 1991 Aug;34(8):1065–8. Available from: http://doi.wiley.com/10.1002/art.1780340819spa
dc.relation.referencesBedell SE, Bush BT. Erythrocyte sedimentation rate. From folklore to facts. Am J Med [Internet]. 1985 Jun;78(6 Pt 1):1001–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4014259spa
dc.relation.referencesShearn MA, Kang IY. Effect of age and sex on the erythrocyte sedimentation rate. J Rheumatol [Internet]. 1986 Apr;13(2):297–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3723495spa
dc.relation.referencesFabry TL. Mechanism of erythrocyte aggregation and sedimentation. Blood [Internet]. 1987 Nov;70(5):1572–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3663946spa
dc.relation.referencesFabry TL. Mechanism of erythrocyte aggregation and sedimentation. Blood [Internet]. 1987 Nov;70(5):1572–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3663946spa
dc.relation.referencesPepys MB. C-reactive protein fifty years on. Lancet (London, England) [Internet]. 1981 Mar 21;1(8221):653–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6110874spa
dc.relation.referencesGewurz H, Mold C, Siegel J, Fiedel B. C-reactive protein and the acute phase response. Adv Intern Med [Internet]. 1982;27:345–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7041546spa
dc.relation.referencesTishler M, Caspi D, Yaron M. C-reactive protein levels in patients with rheumatoid arthritis: the impact of therapy. Clin Rheumatol [Internet]. 1985 Sep;4(3):321–4. Available from: http://link.springer.com/10.1007/BF02031616spa
dc.relation.referencesLarsen A. The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. Scand J Rheumatol [Internet]. 1988;17(2):123–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3387929spa
dc.relation.referencesIm CH, Kang EH, Ryu HJ, Lee JH, Lee EY, Lee YJ, et al. Anti-cyclic citrullinated peptide antibody is associated with radiographic erosion in rheumatoid arthritis independently of shared epitope status. Rheumatol Int [Internet]. 2009 Jan;29(3):251–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18751982spa
dc.relation.referencesWilder RL, Sternberg EM. Neuroendocrine hormonal factors in rheumatoid arthritis and related conditions. Curr Opin Rheumatol [Internet]. 1990 Jun;2(3):436–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2203424spa
dc.relation.referencesAhmed SA, Hissong BD, Verthelyi D, Donner K, Becker K, Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: Possible role of estrogenic compounds. Environ Health Perspect. 1999;107(SUPPL. 5):681–6.spa
dc.relation.referencesFeng J, Chen Q, Yu F, Wang Z, Chen S, Jin Z, et al. Body Mass Index and Risk of Rheumatoid Arthritis: A Meta-Analysis of Observational Studies. Medicine (Baltimore) [Internet]. 2016;95(8):e2859. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26937917spa
dc.relation.referencesUnriza-Puin S, Bautista-Molano W, Lafaurie GI, Valle-O??ate R, Chalem P, Chila-Moreno L, et al. Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives? Clin Rheumatol [Internet]. 2017;36(4):799–806. Available from: http://dx.doi.org/10.1007/s10067-016-3519-zspa
dc.relation.referencesGremese E, Tolusso B, Gigante MR, Ferraccioli G. Obesity as a Risk and Severity Factor in Rheumatic Diseases (Autoimmune Chronic Inflammatory Diseases). Front Immunol [Internet]. 2014 Nov 11;5. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2014.00576/abstractspa
dc.relation.referencesBello-Gualtero JM, Lafaurie GI, Hoyos LX, Castillo DM, De-Avila J, Munevar JC, et al. Periodontal Disease in Individuals With a Genetic Risk of Developing Arthritis and Early Rheumatoid Arthritis: A Cross-Sectional Study. J Periodontol [Internet]. 2016 Apr;87(4):346–56. Available from: http://doi.wiley.com/10.1902/jop.2015.150455spa
dc.relation.referencesAuger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, et al. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum [Internet]. 2005 Nov;52(11):3424–32. Available from: http://doi.wiley.com/10.1002/art.21391spa
dc.relation.referencesBright R, Thiele GM, Manavis J, Mikuls TR, Payne JB, Bartold PM. Gingival tissue, an extrasynovial source of malondialdehyde-acetaldehyde adducts, citrullinated and carbamylated proteins. J Periodontal Res [Internet]. 2017 Oct 17; Available from: http://doi.wiley.com/10.1111/jre.12486spa
dc.relation.referencesFreire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol 2000 [Internet]. 2013 Oct;63(1):149–64. Available from: http://doi.wiley.com/10.1111/prd.12034spa
dc.rights.accessrightsinfo:eu-repo/semantics/closedAccessspa
dc.rights.creativecommonsAtribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)spa
dc.subject.lembEnfermedad Autoinmune
dc.subject.lembAutoautoanticuerpos
dc.subject.proposalAnticuerposspa
dc.subject.proposalArtritisspa
dc.subject.proposalAutoinmunidadspa
dc.subject.proposalCarbamilaciónspa
dc.subject.proposalDiagnosticospa
dc.type.coarhttp://purl.org/coar/resource_type/c_7a1fspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/bachelorThesisspa
dc.type.redcolhttps://purl.org/redcol/resource_type/TPspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.rights.coarhttp://purl.org/coar/access_right/c_14cbspa


Ficheros en el ítem

Thumbnail
Nombre:
Presentación final.pdf
Tamaño:
1.056Mb
Formato:
PDF
Ver/
Thumbnail
Nombre:
Documento final modificado.pdf
Tamaño:
1.077Mb
Formato:
PDF
Ver/
Thumbnail
Nombre:
Documento final modificado FORMATO ...
Tamaño:
307.7Kb
Formato:
PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2018
Excepto si se señala otra cosa, la licencia del ítem se describe como Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2018